Enoxaparin pretreatment effect on local and systemic inflammation biomarkers in the animal burn model

No abstract is available for this paper.

• Publication year

  2018

• Venue

  InflammoPharmacology

• Publication date

  2018-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10787-018-0444-6PMID 29549537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design and Testing of an Experimental Steam-Induced Burn Model in Rats

  2017cited by this paper
• Cross Talk Pathways Between Coagulation and Inflammation.

  2016cited by this paper
• May your New Year be happy and prosperous with “Thrombosis and Haemostasis”

  2016cited by this paper
• Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate?

  2016cited by this paper
• [Assessment of local and systemic inflammatory parameters of peripheral burn in an animal model].

  2016cited by this paper
• Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran.

  2016cited by this paper
• Low molecular weight heparin may prevent acute lung injury induced by sepsis in rats.

  2015cited by this paper
• Diurnal changes in ouabain-sensitive Na+,K+-ATPase activity in the rat spinal dorsal horn

  2015cited by this paper
• Age- and Sex-Associated Effects on Acute-Phase Proteins in Göttingen Minipigs.

  2015cited by this paper
• Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism

  2015cited by this paper
• Systemic changes following carrageenan-induced paw inflammation in rats

  2015cited by this paper
• Quantitative measurements in capsule endoscopy

  2015cited by this paper
• Non-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals

  2015cited by this paper
• Low Molecular Weight Heparin (LMWH) Improves Peritoneal Function and Inhibits Peritoneal Fibrosis Possibly through Suppression of HIF-1α, VEGF and TGF-β1

  2015cited by this paper
• Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial

  2014cited by this paper
• Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo

  2014cited by this paper
• Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.

  2014cited by this paper
• Two faces of inflammation: an immunopharmacological view.

  2014cited by this paper
• Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study

  2014cited by this paper
• Possible Potentiation by Certain Antioxidants of the Anti-Inflammatory Effects of Diclofenac in Rats

  2014cited by this paper
• Targeting factor Xa and thrombin: impact on coagulation and beyond

  2013cited by this paper
• Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats

  2012cited by this paper
• Efecto de la indometacina sobre la expresión de proteínas y del canal de sodio Nav1.3 en el asta dorsal medular de ratas, inducidos por una inflamación periférica aguda

  2012cited by this paper
• An optimized animal model for partial and total skin thickness burns studies.

  2011cited by this paper
• Nociceptive behavior following hindpaw burn injury in young rats: response to systemic morphine.

  2011cited by this paper
• The coagulant response in sepsis and inflammation

  2010cited by this paper
• Blood coagulation as an intrinsic pathway for proinflammation: a mini review.

  2010cited by this paper
• Effect of tetramethylpyrazine on DRG neuron P2X3 receptor involved in transmitting pain after burn.

  2010cited by this paper
• ENOXAPARIN ATTENUATES ENDOTHELIAL DAMAGE WITH LESS BLEEDING COMPARED WITH UNFRACTIONATED HEPARIN IN ENDOTOXEMIC RATS

  2009cited by this paper
• Thrombin physiology and pathophysiology.

  2009cited by this paper
• CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF‐κB and ERK 1/2 MAPK pathway

  2009cited by this paper
• Crosstalk between inflammation and thrombosis.

  2008cited by this paper
• C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells

  2008cited by this paper
• Reprint of Crosstalk between inflammation and thrombosis

  2008cited by this paper
• C-Reactive Protein Enhances Tissue Factor Expression by Vascular Smooth Muscle Cells: Mechanisms and In Vivo Significance

  2008cited by this paper
• The anti-inflammatory effects of heparin and related compounds.

  2008cited by this paper
• Factor Xa: at the crossroads between coagulation and signaling in physiology and disease.

  2008cited by this paper
• Heparin and low-molecular-weight heparin

  2008cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.

  2007cited by this paper
• Haemostatic imbalance following carrageenan-induced rat paw oedema.

  2007cited by this paper
• The mouse ascending: perspectives for human-disease models

  2007cited by this paper
• Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

  2006cited by this paper
• Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular- Weight Heparin for Acute Treatment of Venous Thromboembolism

  2006cited by this paper
• C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells.

  2006cited by this paper
• ABC of wound healing: Burns

  2006cited by this paper
• C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells.

  2005cited by this paper
• The interactions between inflammation and coagulation

  2005cited by this paper
• Normal expression and inflammation-induced changes of Na and Na/K ATPase activity in spinal dorsal horn of the rat.

  2005cited by this paper
• Crosstalk between inflammation and thrombosis.

  2004cited by this paper
• Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Inflammation induced increase of fluoride resistant acid phosphatase (FRAP) activity in the spinal dorsal horn in rats.

  2003cited by this paper
• Dalteparin sodium prevents liver injury due to lipopolysaccharide in rat through suppression of tumor necrosis factor-alpha production by Kupffer cells.

  2003cited by this paper
• Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia

  2003cited by this paper
• Effect of enoxaparin on high glucose-induced activation of endothelial cells.

  2003cited by this paper
• C-reactive protein: a critical update.

  2003cited by this paper
• Novel drug development opportunities for heparin

  2002cited by this paper
• Inflammatory response in the acute phase of deep vein thrombosis.

  2002cited by this paper
• Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.

  2001cited by this paper
• PAST: PALEONTOLOGICAL STATISTICAL SOFTWARE PACKAGE FOR EDUCATION AND DATA ANALYSIS

  2001cited by this paper
• Heparin in the treatment of burns: a review.

  2001cited by this paper
• Heparin and low‐molecular‐weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats

  2001cited by this paper
• Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters.

  2000cited by this paper
• Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin.

  1999cited by this paper
• Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

  1999cited by this paper
• Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells.

  1999cited by this paper
• Enhancement of vascular permeability by specific activation of protease‐activated receptor‐1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxide

  1999cited by this paper
• Tumor necrosis factor-alpha- and interleukin-6-triggered mast cell development from mouse spleen cells.

  1997cited by this paper
• Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.

  1997cited by this paper
• Tumor Necrosis Factor-α– and Interleukin-6–Triggered Mast Cell Development From Mouse Spleen Cells

  1997cited by this paper
• Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.

  1993cited by this paper
• C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

  1993cited by this paper
• C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor.

  1993cited by this paper
• The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state.

  1992cited by this paper
• A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation.

  1984cited by this paper
• A standard animal burn.

  1968cited by this paper
• A new method for the determination of fibrinogen in small samples of plasma.

  1951cited by this paper
• Uva-dare (digital Academic Repository) Tissue Factor Pathway Inhibitor Does Not Influence Inflammatory Pathways during Human Endotoxemia

  year unknowncited by this paper

• Altered descending modulation in patients with chronic primary low back pain assessed by non-invasive functional near-infrared spectroscopy

  2025cites this paper
• The Impact of Obesity on Pain Perception During and After Subcutaneous Injections: A Cross-Sectional Analysis

  2024cites this paper
• Enoxaparin sodium bone cement plays an anti-inflammatory immunomodulatory role by inducing the polarization of M2 macrophages

  2023cites this paper
• Kinetics of Inflammatory Mediators in the Immune Response to Burn Injury: Systematic Review and Meta-Analysis of Animal Studies.

  2023cites this paper
• A 3-O-sulfated heparan sulfate dodecasaccharide (12-mer) suppresses thromboinflammation and attenuates early organ injury following trauma and hemorrhagic shock

  2023cites this paper
• Venous Thromboembolism in Sepsis: From Bench to Bedside

  2022cites this paper
• Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study

  2021cites this paper
• Research progress on action mechanism and clinical application of low molecular weight heparin

  year unknowncites this paper